Protea Biosciences Group filed for Chapter 11 protection with the U.S. Bankruptcy Court in the Northern District of West Virginia, case number 17-01200. The Company, which provides molecular information, is represented by Christopher P. Schueller of Buchanan Ingersoll & Rooney.
The Company also announced that it recently accepted the resignation of Patrick Gallagher from his position as a member of the board. According to documents filed with the SEC, “The Company chose to seek bankruptcy protection after due consideration and upon the advice and recommendations of the Company’s chief restructuring officer, Compass Advisory Partners, LLC (the ‘CRO’).”
Read more Protea bankruptcy news.
The post Protea Biosciences Bankruptcy appeared first on Daily Bankrupt Company Updates | Bankrupt Company News.